Insider Transactions in Q4 2022 at Verve Therapeutics, Inc. (VERV)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+45.78%
|
$72,000
$2.87 P/Share
|
|
Dec 01
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
865
-11.54%
|
$19,030
$22.95 P/Share
|
|
Nov 29
2022
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
554
-20.22%
|
$12,188
$22.1 P/Share
|
|
Nov 29
2022
|
Allison Dorval Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+40.63%
|
-
|
|
Nov 04
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
48,583
-0.38%
|
$1,554,656
$32.0 P/Share
|
|
Nov 04
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
48,583
-0.79%
|
-
|
|
Nov 04
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
97,166
-45.37%
|
$3,109,312
$32.0 P/Share
|
|
Nov 04
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
48,583
-0.79%
|
-
|
|
Nov 03
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
49,568
-0.38%
|
$1,635,744
$33.1 P/Share
|
|
Nov 03
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
49,569
-0.8%
|
-
|
|
Nov 03
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
99,137
-39.94%
|
$3,271,521
$33.1 P/Share
|
|
Nov 03
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
49,569
-0.8%
|
-
|
|
Nov 02
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
28,652
-0.22%
|
$1,002,820
$35.94 P/Share
|
|
Nov 02
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
28,651
-0.46%
|
-
|
|
Nov 02
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
57,303
-31.17%
|
$2,005,605
$35.94 P/Share
|
|
Nov 02
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
28,651
-0.46%
|
-
|
|
Nov 01
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
31,963
-0.24%
|
$1,182,631
$37.72 P/Share
|
|
Nov 01
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
31,963
-0.51%
|
-
|
|
Nov 01
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
63,926
-47.1%
|
$2,365,262
$37.72 P/Share
|
|
Nov 01
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
31,963
-0.51%
|
-
|
|
Oct 31
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
53,696
-0.3%
|
$2,094,144
$39.41 P/Share
|
|
Oct 31
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
53,697
-0.85%
|
-
|
|
Oct 31
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
107,393
-40.22%
|
$4,188,327
$39.41 P/Share
|
|
Oct 31
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
53,697
-0.85%
|
-
|
|
Oct 28
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-60.14%
|
$390,000
$39.9 P/Share
|
|
Oct 28
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.55%
|
$10,000
$1.48 P/Share
|
|
Oct 03
2022
|
Sekar Kathiresan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-4.73%
|
$1,700,000
$34.04 P/Share
|
|
Oct 03
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.97%
|
$50,000
$1.39 P/Share
|